Correct Definition and Reference of the Term “Status Gelasticus”

Yu‐tze Ng

DOI: https://doi.org/10.1177/0883073808320622

2008-02-20

Journal of Child Neurology

Abstract:In an interesting case report by Shahar et al, the incorrect definition and reference for “status gelasticus” was quoted. We originally coined the term status gelasticus for a presentation at the 2004 meeting of the Southern Pediatric Neurology Society (abstract published in the Journal of Child Neurology). We described a 30-monthold boy who underwent successful emergent transcallosal resection of his hypothalamic hamartoma for this condition, which had persisted for nearly 2 months. In the subsequently published case report appearing a year later, we indicated that status gelasticus is “near continuous gelastic-seizure (laughing) activity.” In response to the 2005 publication by Palmini et al of a patient with status gelasticus, we clarified the definition of status gelasticus as “a prolonged cluster of gelastic seizures (i.e., for greater than 20–30 minutes, a period similar to that of status epilepticus)” and reiterated this in a later publication. It was good to learn that the patient of Shahar et al responded well to small doses of clonazepam and that the abundance of benzodiazepine receptors in the hypothalamic region could explain the effect. Unfortunately, we have seen many patients with epilepsy symptomatic from hypothalamic hamartoma who have failed numerous antiepileptic drugs, including the various benzodiazepines. The hypothalamic hamartoma, with its wide spectrum of clinical presentations, seems to be the best example of subcortical epileptogenesis and encephalopathy. The traditional belief has been that the parahypothalamic (pedunculated form) type of hypothalamic hamartoma typically presents with isolated precocious puberty, whereas the intrahypothalamic (sessile) subtype presents with the epileptic encephalopathy picture including refractory epilepsy and the trademark gelastic seizures. However, as more patients have been accumulated, a large overlap between the various subtypes and clinical pictures has become apparent. Likely, there are also “normal people” who have asymptomatic hypothalamic hamartomas. We have had good surgical outcomes and excellent seizure response rates following operations on many patients from among the more refractory (epilepsy) group. Long-term follow-up of our most recent 37 hypothalamic hamartoma patients with refractory symptomatic epilepsy who were treated with endoscopic resection resulted in 49% becoming seizure-free and 93% with greater than 50% reduction in seizure frequency. In addition, duration of hospital stay was significantly shorter than our previously published group of patients who had been treated by transcallosal resection. Thus, hypothalamic hamartoma patients can present with a wide range of clinical features from (near) normal to isolated precocious puberty to severe progressive epileptic encephalopathy. Treatment for the epileptic patients should be individualized, probably in a systematic stepwise manner from low-dose antiepileptic drug monotherapy to multiple antiepileptic drugs to surgery as necessary. However, it is important to recognize that several patients appear to have a developmental regression if there is delay in curative treatment (surgical resection or gamma knife surgery) of refractory seizures. Therefore, as soon as it becomes clear that ongoing medical management will be unsuccessful, timely consideration of surgical interventions is necessary.